Johnson M A, Yamamoto T, Anderson J P. "一种阿托吉泮杂质4的合成方法" [P]. US Patent, US 10761368 B2, 2025-02-23.
发明人高志强,杨光,罗永刚. "Method for the Synthesis of Atogepant Impurity 4" [P]. 中国发明专利, 专利号 CN 117419334 A, 授权公告日 2018-12-27.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 阿托吉泮杂质4 in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 671, (11), 4354-4382.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿托吉泮杂质4 as an Impurity". Talanta, 2015, 119, (1), 7899-7921.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Atogepant Impurity 4 Using HRMS and NMR". Sci. Total Environ., 2016, 1474, (9), 9686-9705.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 阿托吉泮杂质4 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2015, 893, 6045-6059.